Search Results - "Messner, Hans A"

A systematic review of transfusion-associated graft-versus-host disease by Kopolovic, Ilana, Ostro, Jackie, Tsubota, Hideki, Lin, Yulia, Cserti-Gazdewich, Christine M., Messner, Hans A., Keir, Amy K., DenHollander, Neal, Dzik, Walter S., Callum, Jeannie

“…Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of blood transfusion. The clinicolaboratory features of TA-GVHD and the…”
Get full text

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia by DONG HWAN KIM, SRIHARSHA, Lakshmi, WEI XU, KAMEL-REID, Suzanne, XIANGDONG LIU, SIMINOVITCH, Katherine, MESSNER, Hans A, LIPTON, Jeffrey H

“…Purpose: Imatinib resistance is major cause of imatinib mesylate (IM) treatment failure in chronic myeloid leukemia (CML) patients. Several cellular and…”
Get full text

Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study by Devins, Gerald M., Mah, Kenneth, Messner, Hans A., Xenocostas, Anargyros, Gauvin, Lise, Lipton, Jeffrey H.

“…Background Allogeneic hematopoietic cell transplantation (HCT) affects quality of life (QOL). Patient-reported outcomes examine symptoms, side effects,…”
Get full text

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant by Hirama, Takashi, Brode, Sarah K, Beswick, Jenifer, Law, Arjun D, Lam, Wilson, Michelis, Fotios V, Thyagu, Santhosh, Viswabandya, Auro, Lipton, Jeffrey H, Messner, Hans A, Kim, Dennis Dong Hwan, Marras, Theodore K

“…Allogeneic haematopoietic stem cell transplant (alloHCT) recipients are at risk for a variety of opportunistic infections. While typical bacterial infections…”
Get full text

Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia by Khalil, Manar M. I., Lipton, Jeffrey H., Atenafu, Eshetu G., Gupta, Vikas, Kim, Dennis D., Kuruvilla, John, Viswabandya, Auro, Messner, Hans A., Michelis, Fotios V.

“…Objective To investigate the prognostic impact of the individual component comorbidities of the hematopoietic cell transplant comorbidity index (HCT‐CI) in…”
Get full text

Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience by Aljasem, Hassan A., Messner, Hans A., Lipton, Jeffrey H., Kim, Dennis Dong Hwan, Viswabandya, Auro, Thyagu, Santhosh, Deotare, Uday, Michelis, Fotios V.

“…Objective Second allogeneic hematopoietic cell transplantation (HCT) may be indicated following relapse or graft failure following first HCT. Our retrospective…”
Get full text

Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies by Khalil, Manar M. I., Messner, Hans A., Lipton, Jeffrey H., Kim, Dennis D., Viswabandya, Auro, Thyagu, Santhosh, Deotare, Uday, Michelis, Fotios V.

“…We have been using a combination of fludarabine/busulfan plus low-dose total body irradiation (TBI) as the reduced-intensity conditioning (RIC) regimen for…”
Get full text

Nocturnal Hemodialysis Improves Erythropoietin Responsiveness and Growth of Hematopoietic Stem Cells by CHAN, Christopher T, LIU, Peter P, ARAB, Sara, JAMAL, Nazir, MESSNER, Hans A

“…Nocturnal home hemodialysis (NHD) is associated with an increase in hemoglobin level. We hypothesized that NHD enhances the removal of toxins of hematopoietic…”
Get full text

Equally Interchangeable? How Sex and Gender Affect Transplantation by Melk, Anette, Babitsch, Birgit, Borchert-Mörlins, Bianca, Claas, Frans, Dipchand, Anne I, Eifert, Sandra, Eiz-Vesper, Britta, Epping, Jelena, Falk, Christine S, Foster, Bethany, Geyer, Siegfried, Gjertson, David, Greer, Mark, Haubitz, Marion, Lau, Ashley, Maecker-Kolhoff, Britta, Memaran, Nima, Messner, Hans A, Ostendorf, Karen, Samuel, Undine, Schmidt, Bernhard M.W, Tullius, Stefan G, West, Lori, Wong, Germaine, Zimmermann, Tanja, Berenguer, Marina

“…Organ transplantation as an option to overcome end-stage diseases is common in countries with advanced healthcare systems and is increasingly provided in…”
Get full text

Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process by Fingrut, Warren, Messner, Hans A., Allan, David

“…Patients in need of hematopoietic stem cell transplantation often cannot find a suitable HLA-matched donor in their families and rely on unrelated donors…”
Get full text

Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms by Kennedy, James A., Atenafu, Eshetu G., Messner, Hans A., Craddock, Kenneth J., Brandwein, Joseph M., Lipton, Jeffrey H., Minden, Mark D., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., Gupta, Vikas

“…Leukemic transformation (LT) is a rare but fatal complication of Philadelphia-negative myeloproliferative neoplasms (MPNs) for which optimal treatment…”
Get full text

Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation by Kim, Dong Hwan, Kumar, Deepali, Messner, Hans A., Minden, Mark, Gupta, Vikas, Kuruvilla, John, Chae, Yee Soo, Sohn, Sang Kyun, Lipton, Jeffrey H.

“…:  Varicella‐Zoster virus infection (VZV) has a high incidence post‐allogeneic peripheral blood stem cell transplant (PBSCT). However, data regarding long‐term…”
Get full text

Prognostic implication of pre-transplant FEV 1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation by Novitzky-Basso, Igor, Lam, Wilson, Chiarello, Caden, Pasic, Ivan, Law, Arjun D, Michelis, Fotios V, Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey H, Kumar, Rajat, Mattsson, Jonas, Messner, Hans A, Marras, Theodore K, Mittoo, Shikha, Kim, Dennis Dong Hwan

“…Pre-transplant pulmonary function testing (PFT) is essential before allogeneic hematopoietic stem cell transplant (HCT), yet the optimal cutoff value for…”
Get full text

Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation by Deotare, Uday, Atenafu, Eshetu G., Loach, David, Michelis, Fotios V., Kim, Dennis (Dong-Hwan), Thyagu, Santhosh, Lipton, Jeffrey H., Messner, Hans A., Viswabandya, Auro

Get full text

Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation by Mayo, Samantha J., Messner, Hans A., Rourke, Sean B., Howell, Doris, Victor, J. Charles, Lipton, Jeffrey H., Kuruvilla, J., Gutpa, Vikas, Kim, Dennis Dong Hwan, Michelis, Fotios V., Metcalfe, Kelly

“…Certain subgroups of patients may be particularly vulnerable to cognitive decline after treatment with allogeneic hematopoietic stem cell transplant (HCT). The…”
Get full text

Prognostic implication of pre‐transplant FEV1 on long‐term outcomes following allogeneic hematopoietic stem cell transplantation by Novitzky‐Basso, Igor, Lam, Wilson, Chiarello, Caden, Pasic, Ivan, Law, Arjun D., Michelis, Fotios V., Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey H., Kumar, Rajat, Mattsson, Jonas, Messner, Hans A., Marras, Theodore K., Mittoo, Shikha, Kim, Dennis Dong Hwan

“…Background Pre‐transplant pulmonary function testing (PFT) is essential before allogeneic hematopoietic stem cell transplant (HCT), yet the optimal cutoff…”
Get full text

Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1 by Bourlon, Christianne, Lipton, Jeffrey H., Deotare, Uday, Gupta, Vikas, Kim, Dennis D., Kuruvilla, John, Viswabandya, Auro, Thyagu, Santhosh, Messner, Hans A., Michelis, Fotios V.

“…Objective Extramedullary disease (EMD) at diagnosis of acute myeloid leukemia (AML) has been associated with increased risk of relapse and worse outcomes…”
Get full text

Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML by Pasic, Ivan, Da'na, Waleed, Lam, Wilson, Law, Arjun, Lipton, Jeffrey H., Viswabandya, Auro, Kim, Dennis D., Thyagu, Santhosh, Messner, Hans A., Michelis, Fotios V.

“…Objective In individuals with cytogenetically normal (CN) AML, disease risk is estimated using molecular features such as the status of NPM1 and FLT3‐ITD…”
Get full text

Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen by Storring, John M., Minden, Mark D., Kao, Susan, Gupta, Vikas, Schuh, Andre C., Schimmer, Aaron D., Yee, Karen W. L., Kamel‐Reid, Suzanne, Chang, Hong, Lipton, Jeffrey H., Messner, Hans A., Xu, Wei, Brandwein, Joseph M.

“…Summary Between 2000 and 2006, 85 adult BCR‐ABL negative acute lymphoblastic leukaemia (ALL) patients between 18 and 60 years of age were treated using a…”
Get full text

Validation of National Institutes of Health Global Scoring System for Chronic Graft-Versus-Host Disease (GVHD) According to Overall and GVHD-Specific Survival by Moon, Joon Ho, Sohn, Sang Kyun, Lambie, Anna, Ellis, Laura, Hamad, Nada, Uhm, Jieun, Gupta, Vikas, Lipton, Jeffrey H, Messner, Hans A, Kuruvilla, John, Kim, Dennis

“…Abstract A new severity grading system for graft-versus-host disease (GVHD) was established by the National Institutes of Health (NIH) consensus criteria…”
Get full text